×

CellRapeutics™ CD3+ T Cells from Human Immunodeficiency Virus HIV Donor (XS-0426-XU216)

Online Inquiry  Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This product contains high-purity CD3+ T cells isolated from donors confirmed to be HIV-positive. The T-cell population captures the critical immunological signatures of chronic viral infection, including altered CD4/CD8 ratios and signs of immune exhaustion or senescence. Isolated via high-precision immunomagnetic separation, these cells provide an essential substrate for studying viral reservoirs, T-cell dysfunction, and the efficacy of antiretroviral-related immunotherapeutic strategies.

Specific Inquiry

  • Size:
  Add to Cart

Donor Information

  • Product Name
  • CellRapeutics™ CD3+ T Cells from Human Immunodeficiency Virus HIV Donor
  • Cat. No.
  • XS-0426-XU216
  • Donor Age
  • Young Adult, Middle-Aged
  • Donor Health
  • T cells reflect a state of chronic viral exposure and potential immune exhaustion, often showing altered CD4/CD8 ratios and characteristic markers of persistent cellular activation or senescence.
  • Ethnicity
  • Diverse backgrounds available.
  • Anticoagulant
  • Heparin, formulated to provide superior membrane protection for fragile T-cell populations and minimize HIV-induced syncytia formation during leukapheresis.
  • Additional Donor Information
  • Each lot features CD3+ T cells from HIV-positive donors. Profiles include viral load, CD4/CD8 ratios, and ART status to support viral reservoir and exhaustion research.
  • Clinical Profile
  • Viral load status, CD4+ T-cell count history, and duration of Antiretroviral Therapy.

Additional Information

  • Medication History
  • Available upon request. Records of ART history, CD4+ T-cell count recovery status, and history of treatments affecting T-cell exhaustion markers.
  • Formulation
  • Cryopreserved in specialized freezing medium
  • Cell Purity
  • >90%
  • Cell Viability
  • >90%
  • Mycoplasma Testing
  • Negative
  • Sterility Testing
  • Negative
  • Genetic Stability Testing
  • The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.
  • Application
  • Drug Discovery, Immuno-oncology Research
  • Research Use Only
  • RUO
  • Quality Control
  • Each product batch undergoes rigorous testing for purity, viability, and microbial contamination.
  • Storage
  • Store in liquid nitrogen vapor phase for long-term stability, maintain constant temperatures below -150°C to prevent loss of viability.
  • Shiping
  • Dry Ice
  • Handling Notes
  • Perform rapid thawing in a 37°C water bath and dilute slowly with pre-warmed media to ensure optimal cell recovery and function.
  • Warnings
  • Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.
  • Size
  • 2.5E7 cells/vial, 5E7 cells/vial
  • Keywords
  • CellRapeutics™ CD3+ T Cells from Human Immunodeficiency Virus HIV Donor, CD3+ T Cells, Human Immunodeficiency Virus HIV

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ CD3+ T Cells from Human Immunodeficiency Virus HIV Donor (XS-0426-XU216). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Immune Cell Products

Monocyte Products

Dendritic Cell Products

PBMC Products

NK Cell Products

T Cell Products

Mouse Cell Products

B Cell Products

Stem Cell Products

Online Inquiry
Products
Global Services. (Creative Biolabs Authorized)
Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

Key Updates
Newsletter. (Creative Biolabs Authorized) NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution. (Creative Biolabs Authorized) NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
Novel Solution. (Creative Biolabs Authorized) NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
New Technology. (Creative Biolabs Authorized) NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.
Copyright © 2026 Creative Biolabs. All Rights Reserved
  • 0
  • 0
Cart
    Go to checkout